BioNTech SE ADR [NASDAQ: BNTX] traded at a high on Wednesday, posting a 11.11 gain after which it closed the day’ session at $102.30.
The results of the trading session contributed to over 3600103 shares changing hands. Over the past one week, the price volatility of BioNTech SE ADR stands at 4.04% while the volatility over the past one month is 2.90%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for BNTX stock reached $24.32 billion, with 237.73 million shares outstanding and 237.14 million shares in the current float. Compared to the average trading volume of 594.02K shares, BNTX reached a trading volume of 3600103 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioNTech SE ADR [BNTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNTX shares is $115.28 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNTX stock is a recommendation set at 2.43. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for BioNTech SE ADR shares, keeping their opinion on the stock as In-line, with their previous recommendation back on May 14, 2024. While these analysts kept the previous recommendation, BMO Capital Markets raised their target price to Outperform. The new note on the price target was released on February 23, 2024, representing the official price target for BioNTech SE ADR stock. On December 01, 2023, analysts decreased their price target for BNTX shares from 106 to 99.
The Average True Range (ATR) for BioNTech SE ADR is set at 2.84, with the Price to Sales ratio for BNTX stock in the period of the last 12 months amounting to 8.24. The Price to Book ratio for the last quarter was 1.13, with the Price to Cash per share for the same quarter was set at 40.78. Price to Free Cash Flow for BNTX in the course of the last twelve months was 4.21 with Quick ratio for the last quarter at 11.16.
How has BNTX stock performed recently?
BioNTech SE ADR [BNTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.95. With this latest performance, BNTX shares gained by 15.61% in over the last four-week period, additionally plugging by 3.51% over the last 6 months – not to mention a drop of -4.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNTX stock in for the last two-week period is set at 73.69, with the RSI for the last a single of trading hit 79.31, and the three-weeks RSI is set at 68.49 for BioNTech SE ADR [BNTX]. The present Moving Average for the last 50 days of trading for this stock 90.74, while it was recorded at 94.09 for the last single week of trading, and 99.58 for the last 200 days.
BioNTech SE ADR [BNTX]: Deeper insight into the fundamentals
BioNTech SE ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.16 and a Current Ratio set at 11.38.
Insider trade positions for BioNTech SE ADR [BNTX]
The top three institutional holders of BNTX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in BNTX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in BNTX stock with ownership which is approximately 5.8386%.
